Urolithin A Produced
by Novel Microbial Fermentation
Possesses Anti-aging Effects by Improving Mitophagy and Reducing Reactive
Oxygen Species in Caenorhabditis elegans
Urolithin, intestinal microbiota metabolites of ellagitannin-rich
foods, exhibit anti-aging activities. However, urolithin A is significantly
superior to other types of urolithin with regard to this anti-aging
function. This study aimed to screen edible urolithin A-producing
strains of bacteria and explore the corresponding anti-aging efficacy
of fermented products produced by these strains using Caenorhabditis elegans as a model. Our results showed
that the Lactobacillus plantarum strains
CCFM1286, CCFM1290, and CCFM1291 converted ellagitannin to produce
urolithin A; the corresponding yields of urolithin A from these strains
were 15.90 ± 1.46, 24.70 ± 0.82, and 32.01 ± 0.97 μM,
respectively. Furthermore, it was found that the pomegranate juice
extracts fermented by the CCFM1286, CCFM1290, and CCFM1291 strains
of L. plantarum could extend lifespan
by 26.04 ± 0.12, 32.05 ± 0.14, and 46.33 ± 0.12%, respectively,
by improving mitochondrial function and/or reducing reactive oxygen
species levels. These findings highlight the potential application
of this fermentation in the subsequent development of anti-aging products